Peter Paul Yu, MD, FASCO, FACP, physician-in-chief, Hartford HealthCare Cancer Center, discusses the shift toward interoperability among electronic health record systems and efforts needed to accelerate this shift.
Peter Paul Yu, MD, FASCO, FACP, physician-in-chief, Hartford HealthCare Cancer Center, discusses the shift toward interoperability among electronic health record systems and efforts needed to accelerate this shift.
Transcript
How much progress has there been in the move toward interoperability among EHR systems? What efforts are needed to accelerate the shift?
Most people when they talk about interoperability, they talk about it in the way of how do you get it from one electronic health record (EHR) into the other EHR, and that’s relevant, if the patient is moving from Seattle to Kansas City and you need to move records across, and it’s relevant if you were in a cardiologist's office yesterday and today you’re seeing the orthopedic doctor and you need to move it around. That’s generally what people talk about in terms of interoperability.
From an oncologist point of view, I think it’s somewhat different. From an oncologist point of view, I think it’s more about: how do you get the data that’s in an electronic health record connected to the data that’s in the radiation oncologist’s record, which is driving the Linux, and how do you get it connected to the pathology office, which has their detailed pathology report information? How do you move that into the cancer registry, so you can satisfy your reporting requirements? For oncology, it’s not so much about moving it from one EHR to another EHR, its more about how do we aggregate the whole sum of the patient’s cancer experience in a database?
Having defined that, the bad news is that there’s very little going on there because when you’re talking about one EHR to another EHR, there is a basic data set that’s in common to all your charge. The representation and how its captured is different, but the data is, in theory, similar, and you can move it around. And when you take it out of one EHR, you can dump it into another spot, another EHR. When you’re talking about moving things like genomic data from a precision medicine next-generation sequencing test and you have 500 mutations to report on and there’s not a single landing field for each of those mutations in the EHR, now you have a really big problem. So, I think this is an area that we’ve just started the discussion and awareness of, but I’d say right now we’re far from even recognizing the importance of this need.
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
AUA Session Highlights the General Urologist’s Role in Gender-Affirming Care
May 7th 2024During her session, Polina Reyblat, MD, Kaiser Permanente Los Angeles Medical Center, highlighted best practices urologists should incorporate to make transgender and gender-diverse patients comfortable during physical exams and avoid retraumatization.
Read More